Results 231 to 240 of about 631,021 (368)
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló +5 more
wiley +1 more source
Aim Clinically, interstitial lung disease (ILD) is a heterogeneous group of respiratory disorders. Due to their low incidence, pharmacovigilance database analysis is useful to detect them. Precise diagnosis is challenging as well as coding in these databases. Query criteria are among the key elements for a good signal detection.
Romane Freppel +4 more
wiley +1 more source
Microcuff versus Uncuffed Oral Ring-Adair-Elwyn Tube: Is Cuff the Only Difference?
Priya Rudingwa +3 more
doaj +1 more source
Human airway material characterization via inverse finite element analysis and neural network surrogate. [PDF]
Badrou A +3 more
europepmc +1 more source
Medical versus science students: Knowledge, perceptions and learning of core pharmacology concepts
Aims Pharmacology is a core discipline underpinning both medical and biomedical science education, essential for understanding drug action, safety and therapeutic efficacy. This study compared pharmacology knowledge, perceptions and learning experiences between second‐year medical and science students to evaluate how effectively each curriculum ...
Zina Alfahl +3 more
wiley +1 more source
Airway Management With a GlideScope® Spectrum LoPro Blade in a Child With Giant Facial Rhabdomyosarcoma: A Case Report. [PDF]
Kosokabe M +3 more
europepmc +1 more source
Extreme Supersaturation in Human Airways (ANSYS Fluent Dataset)
Ishmatov, Aleksandr
openalex +1 more source
Aim The number of pregnancies among women with cystic fibrosis (wwCF) has steadily increased over the past decade. However, the pharmacokinetics (PK) of elexacaftor–tezacaftor–ivacaftor (ETI) during gestation remains uncharacterized, despite its widespread use in this population.
Paulette Magnas +16 more
wiley +1 more source
Tobramycin pharmacokinetic and pharmacodynamic targets in people with cystic fibrosis
Intravenous tobramycin is a first‐line treatment for Pseudomonas aeruginosa infection in people with cystic fibrosis (CF). Tobramycin exhibits concentration‐dependent activity; however, excess drug exposure can lead to nephrotoxicity and ototoxicity. While dosing typically targets serum peak (Cmax) and trough (Cmin) concentrations, the area under the ...
Kiera H. Harwood +6 more
wiley +1 more source

